Occlutech

Switzerland - SchaffhausenMedical Devices

Focus: Occlutech is a Switzerland-based medical device company specializing in minimally-invasive cardiac closure devices for structural heart defects and heart failure. Founded in 2003, the company operates in the cardiovascular device space with a focused product portfolio.

Cardiovascular

Profile data last refreshed 3h ago · AI intelligence enriched 2w ago

Open Jobs

About Occlutech

AI assessmentNot Hiring

No open roles listed right now. Follow Occlutech to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Occlutech PFO Occluder

Patent Foramen Ovale (Cryptogenic Ischemic Stroke)

Growth

Lead indication in Phase 3 development with robust clinical registry data supporting stroke prevention.

Occlutech PDA Occluder

Patent Ductus Arteriosus

Help build intelligence for Occlutech

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Occlutech PFO Occluder

Stroke

N/A

Clinical Trials (1)

NCT04029233The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

N/A

A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Effic

Paravalvular Leak Device (PLD)

N/A

Clinical Trials (1)

NCT07037446A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Paravalvular Leaks

N/A

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® P

Perimembranous Ventricular Septal Defect

N/A

Clinical Trials (1)

NCT04034498A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

N/A

Catheter implantation of Occlutech AFR device

Various

N/A

Clinical Trials (1)

NCT07421557Expanded Access of Occlutech's Atrial Flow Regulator

N/A

Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

Mitral Paravalvular Leaks (PVL)

N/A

Clinical Trials (1)

NCT03003481Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

N/A

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of O

Heart Diseases

N/A

Clinical Trials (1)

NCT05174442ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

N/A

Occlutech PDA occluder

Patent Ductus Arteriosus

N/A

Clinical Trials (1)

NCT01479218Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

N/A

transcatheter closure of secundum atrial septal defects in patients

Secundum Atrial Septal Defects

N/A

Clinical Trials (1)

NCT04488120Occlutech Septal Occluder (Figulla Flex II) Study

N/A

Occlutech® PDA Occluder

Patent Ductus Arteriosus

N/A

Clinical Trials (1)

NCT05264753Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

N/A

Occlutech muscular ventricular septal defect

Muscular Ventricular Septal Defect

N/A

Clinical Trials (1)

NCT05329350Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

N/A

Pulmonary Embolism and Right-to-Left Shunts

Pulmonary Embolism (PE)

N/A

Clinical Trials (1)

NCT07519876Pulmonary Embolism and Right-to-Left Shunts

N/A

Occlutech AFR Device

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT03022851The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

N/A

Closure of bronchopleural fistula with Occlutech Figulla

Bronchopleural Fistula

N/A

Clinical Trials (1)

NCT01153074Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

N/A

Occlutech AFR device

Heart Failure Low Output

N/A

Clinical Trials (1)

NCT03030274The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

N/A

Investigational PFO Closure Device

Stroke

N/A

Clinical Trials (1)

NCT05069558Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

N/A

Atrial Flow Regulator

Heart Failure With Preserved Ejection Fraction (HFpEF)

N/A

Clinical Trials (2)

NCT05136820Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

N/A

NCT07532369Occlutech AFR Fontan Study

Occlutech Atrial Flow Regulator

Heart Failure

N/A

Clinical Trials (1)

NCT04405583The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

N/A

Implantation of LAA closure device

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02105584Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

N/A

Transcatheter PFO closure

Cryptogenic Ischemic Stroke

Phase 3

Clinical Trials (1)

NCT05387954PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Phase 3

Occlutech

About Occlutech

Why Work Here

Key Products

Watch Out For

Pipeline & Clinical Trials

Open Jobs (0)